OL
Olema Pharmaceuticals, Inc.
OLMA · NASDAQ
$9.82 -1.06% (-$0.11)
1M -8.14%
Market Cap $898.8M
P/E Ratio -
Div. Yield -
ROE 48.22%
Bulios Fair Price
$6.78
31.0% downside
Trenutna cena
$9.82
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica OLMA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
85 /100
Cheap P/B 2.09x
P/E N/A
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 34.30%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 50.92%
Asset turnover 0.00x
ROE 48.22%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 8.86x
Int. coverage N/A
Stability
44 /100
Moderate Beta 1.99x
Profitable years 0
EPS volatility 11.36%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o OLMA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Sean Bohen
Employees
150
Headquarters
San Francisco
Prihajajoči dogodki
09 NOV.
Earnings
Upcoming earnings report